Alkermes to buy Rodin Therapeutics for up to $950m

This article was originally published here

As per the terms of the deal, Rodin’s security holders will secure an upfront cash payment of $100m upon completion of the deal. Rodin is also eligible to

The post Alkermes to buy Rodin Therapeutics for up to $950m appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply